Skip to content

E4 Pharmaceutical Consulting

E4 Biotechnology and Pharmaceutical Consulting. Providing product development (CMC), regulatory, QA/QC and project management support to companies developing new small-molecule drugs, biologics and medical devices.

Welcome!!

Categories

  • Regulatory (2)
    • Regulatory Strategy (1)
    • Regulatory Submissions (2)

E4 Pharmaceutical Consulting

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

RSS FDA News

  • Ups and Downs of Gene Therapy Weighed by FDA’s Marks
    Marks believes the advantages shown so far in gene therapy treatments are enough to move forward aggressively.
  • Drug Manufacturers Accuse UK Government of Sending Industry Mixed Messages
    After agreeing to a voluntary plan to help lower drug prices in the UK, the Association of the British Pharmaceutical Industry (ABPI) has issued a statement today accusing the UK government and England’s National Health Service (NHS) of sending mixed messages to life science companies.
  • FDA Laboratory-Developed Tests Proposal Comments Pour In by Thousands
    AdvaMed, a trade group for medical devicemakers, did not submit a public comment but instead issued a statement on the subject in late September.
  • AstraZeneca Continues Bitter Fight Over IRA’s Drug Price Negotiations
    After agreeing this fall to participate in the Inflation Reduction Act (IRA) drug price negotiation program, AstraZeneca — whose type 2 diabetes therapy Farxiga (dapagliflozin) was among the first 10 drugs singled out for the new cost-cutting measure — is still fighting the government over the program.
  • House Subcommittee Asks FDA for Briefing on Ineffective OTC Drugs
    The House Subcommittee on Health Care and Financial Services has asked the FDA to schedule a briefing with Committee staff no later than Dec. 11 to help with an investigation of the efficacy of OTC drugs after an advisory committee concluded that a commonly used decongestant, phenylephrine, is ineffective.

RSS Pharma Times

  • Lung cancer screening recommended in Scotland, Wales and Northern Ireland
    The disease is one of the leading causes of cancer deaths in the UK
  • Study reveals reducing oxygen levels for children in ICUs will save lives
    Around 20,000 children are admitted to ICUs every year in the UK
  • Secretary of state sets out priorities for UK health and social care systems
    The commitments will make health systems faster, simpler and fairer for patients
  • Study reveals motor neuron region is affected in ALS
    The neurological condition currently affects one in 300 people in the UK
  • KCL molecular communication system to revolutionise drug delivery
    The platform safely and effectively replicates the electric signalling process compounds
  • NIHR invests £55m to tackle health inequalities and outcomes
    Millions of people in the UK are set to benefit from the second wave of funding
Proudly powered by WordPress / Theme: Shoreditch by Automattic.